greeksoup/ stock research

Medtronic (MDT) FY2024 results: revenue $32.4 billion, up 3.6% on the year

Medtronic plc (MDT) reported revenue of $32.4 billion for fiscal 2024, the year ended 26 April 2024, up 3.6% on the year before. Net income was $3.7 billion, down 2.2%, and diluted earnings per share $2.76. The figures are the company's own, from the 10-K it filed with the SEC on 20 June 2024.

Revenue
$32.4 billion
+3.6% on the year
FY2017FY2024
Operating margin
15.9%
17.6% a year earlier
FY2017FY2024
Net income
$3.7 billion
-2.2% on the year
FY2017FY2024
Diluted EPS
$2.76
-2.1% on the year
FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ millionFY2024FY2023FY2022On the yearLast 8 years
Revenue32,36431,22731,686+3.6%
Cost of revenue11,21610,71910,145+4.6%
Gross profit21,14820,50821,541+3.1%
Gross margin65.3%65.7%68.0%
Research and development2,7352,6962,746+1.4%
Selling, general and administrative10,73610,41510,292+3.1%
Operating income5,1445,4855,752-6.2%
Operating margin15.9%17.6%18.2%
Interest expense719636553+13.1%
Pre-tax income4,8375,3645,517-9.8%
Income tax1,1331,580456-28.3%
Effective tax rate23.4%29.5%8.3%
Net income3,6763,7585,039-2.2%
Net margin11.4%12.0%15.9%
Diluted EPS$2.76$2.82$3.73-2.1%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2024FY2023FY2022On the yearLast 8 years
Operating cash flow6,7876,0397,346+12.4%
Capital expenditure1,5871,4591,368+8.8%
Free cash flow5,2004,5805,978+13.5%
Free cash flow margin16.1%14.7%18.9%
Cash from investing-2,366-3,493-1,659
Cash from financing-4,450-4,960-5,336
Depreciation and amortisation2,6472,6972,707-1.9%
Share-based compensation393355359+10.7%
Buybacks2,1386452,544+231.5%
Dividends paid3,6663,6163,383+1.4%
Dividend per share$2.76$2.72$2.52+1.5%
Diluted shares, weighted1,330m1,333m1,351m-0.2%
Shares outstanding at period end1,311m1,331m1,331m-1.5%

Balance sheet

$ millionFY2024FY2023FY2022On the yearLast 8 years
Shareholders' equity50,21451,48352,551-2.5%
Non-controlling interest206182171+13.2%
Debt25,02424,34424,114+2.8%
Operating lease liabilities840869703-3.3%
Finance lease liabilities55.057.056.0-3.5%
Other liabilities13,64214,01313,386-2.6%
Total liabilities and equity89,98190,94890,981-1.1%
Fixed assets6,1315,5695,413+10.1%
Goodwill40,98641,42540,502-1.1%
Intangible assets13,22514,84415,595-10.9%
Investments6,7216,4166,859+4.8%
Cash and equivalents1,2841,5433,714-16.8%
Receivables6,1285,9985,551+2.2%
Inventory5,2175,2934,616-1.4%
Other assets10,2899,8608,731+4.4%
Total assets89,98190,94890,981-1.1%

10-K for the year ended 26 April 2024, filed 20 June 2024: the filing.